Can Fite BioPharma 뉴스 - CANF

기업명	주식 심볼	시장	주식 타입
Can Fite BioPharma Ltd	CANF	AMEX	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.09	4.43%	2.12	08:59:56

개장가	저가	고가	종가	전일 종가
2.03	2.00	2.27	2.09	2.03

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
25/04/2024	20:00	BW	Long-term Complete Response to Can-Fite's Namodenoson in..
15/04/2024	20:00	BW	Can-Fite: Scientific Article Published by KOL Presents..
03/04/2024	20:00	BW	Can-Fite: Submits FDA with an IND Application to Conduct..
28/03/2024	20:00	BW	Can-Fite Reports 2023 Financial Results and Clinical Update
11/03/2024	20:27	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/2024	20:00	BW	Namodenoson Treatment for Pancreatic and Liver Cancer: Data..
28/02/2024	21:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/02/2024	21:00	BW	Can-Fite Broadens its Strong Intellectual Property (IP) for..
15/02/2024	05:32	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
30/01/2024	21:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/01/2024	21:00	BW	Can-Fite Expands the Out-Licensing Deal with Ewopharma to..
29/01/2024	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/01/2024	21:00	BW	Can-Fite: Top Scientific Journal Published Positive Data..
08/01/2024	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
29/12/2023	06:16	EDGAR2	Form F-3/A - Registration statement by foreign private..
20/12/2023	21:09	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/2023	21:00	BW	The Anti-Obesity Effect of Can-Fite’s Namodenoson: Molecular..
18/12/2023	21:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/2023	21:00	BW	Can-Fite Received FDA Positive Response to Psoriasis..
13/12/2023	06:15	EDGAR2	Form F-3 - Registration statement by foreign private issuers
04/12/2023	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/2023	21:00	BW	Can-Fite’s Namodenoson for the Treatment of Pancreatic..
30/11/2023	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/2023	21:00	BW	Can-Fite Reports Third Quarter 2023 Financial Results and..
23/11/2023	06:20	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
23/11/2023	06:15	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/2023	06:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/2023	03:53	GLOBE	Can-Fite Announces Exercise of Warrants for Approximately..
21/11/2023	21:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/2023	21:00	BW	Can-Fite: Complete Response and 6.9 Years Overall Survival..
01/11/2023	20:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/2023	20:00	BW	Can-Fite Issues Business Update: All Clinical Programs and..
30/10/2023	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/2023	20:00	BW	Can Fite: Namodenoson Inhibits Pancreatic Carcinoma..
26/10/2023	20:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/2023	20:00	BW	Can-Fite to Harness Artificial Intelligence to Develop Novel..
10/10/2023	20:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/10/2023	20:00	BW	Can-Fite to Share its Rare Genetic Disease Lowe Syndrome..
27/09/2023	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/09/2023	20:00	BW	Can-Fite Novel Approach for the Treatment of Pancreatic..
07/09/2023	20:25	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/09/2023	20:00	BW	Can-Fite to Share with Investors Latest Oncology and Rare..
02/09/2023	05:16	EDGAR2	Form POS AM - Post-Effective amendments for registration..
02/09/2023	05:15	EDGAR2	Form F-3 - Registration statement by foreign private issuers
31/08/2023	20:12	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/08/2023	20:00	BW	Can-Fite Reports Second Quarter 2023 Financial Results &..
24/08/2023	20:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/08/2023	20:10	BW	Can-Fite Enters Rare Genetic Disease Field Based on..
18/08/2023	20:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/08/2023	20:00	BW	Can-Fite Submitted to FDA a Pediatric Plan to Allow..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

CANF Can Fite BioPharma Ltd

최근 뉴스

CANF 과거 데이터 - 1일

CANF 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Can Fite BioPharma Ltd (CANF) 뉴스

CANF Can Fite BioPharma Ltd

최근 뉴스

CANF 과거 데이터 - 1일

CANF 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기